Aside

logo

Contact Info

Areas of Experience

Language Skills

R
SAS
SQL
VBA

Disclaimer

Made with the R package pagedown.

Last updated on 2025-01-03.

Download a PDF of this CV

Main

Jake Earl

Pharmacist (PharmD), and Health Economist (MS) with clinical and payor experience and in-depth training in Health Economics and Outcomes Research (HEOR).

I have experience working for a Managed Care Organization, have built various economic models, and have conceptualized and conducted multiple Real-World Evidence (RWE) studies with claims data. I thoroughly enjoy health economics and strive to generate meaningful research that depicts a clear and impactful message.

I am currently searching for a position in HEOR that allows me to lead teams in utilizing innovative techniques to generate impactful RWE.

Education

Master of Science, Health Economics and Outcomes Research

University of Washington CHOICE Institute

Seattle, WA

2024 - 2023

Doctor of Pharmacy

University of Utah College of Pharmacy

Salt Lake City, UT

2023 - 2019

  • Viatris Excellence in Pharmacy Award Recipient
  • 2023 AFPE Research Scholarship Nominee (one of two from the college)
  • Conducted Research with the Pharmacy Outcomes Research Center (PORC)

Industry Experience

Post-Doctoral Fellow, HEOR & Data Analytics

Bayer Pharmaceuticals

Whippany, NJ

2024 - 2023

  • Conceptualized and designed Real-World Evidence (RWE) studies to support launch of Kerendia utilizing Optum, Komodo, HealthVerity, and other databases
  • Revised and generated Healthcare Information Exchange (HCEI) decks and RWE posters for external communication
  • Assessed vendor/data capabilities to execute designed stuides
  • Presented research proposals for internal alignment and approval
  • Guided and oversaw vendor activities to ensure timely study execution
  • Assessed economic models and presented on their function and validity

Post-Doctoral Fellow, HEOR

University of Washington CHOICE Institute / Bayer

Seattle, WA

2024 - 2023

  • Generated advanced Markov Models using VBA in Excel for PSA & VOI analyses
  • Conducted RWE research utilizing R, SAS, and SQL with MarketScan data
  • Gained in-depth knowledge in Epidemiology, Biostatistics, and Data Anaysis for application in HEOR

Pharma Consulting, Pharmacist Intern Advanced Experience

Cencora

Carrollton, TX

2023 (6wks)

  • Analyzed pharmaceutical companies and evaluated the impact of their therapies
  • Developed clear and impactful presentations for clients
  • Followed new legislation and delivered internal presenations for education

Managed Care, Pharmacist Intern Advanced Experience

University of Utah Health Plans

Salt Lake City, UT

2023 - 2021

  • Analyzed new therapies and presented coverage criteria to P&T committee
  • Revised and developed prior-authorization (PA) criteria
  • Analyzed claim data to determine adherence and evaluate coverage
  • Examined PA appeals in oncology and other therapeutica areas to determine approval or denial
  • Networked with Key Opinion Leaders (KOLs) to obtain specialized perspective

Inpatient Clinical Pharmacist Intern Advanced Experience

University of Utah Health Hospital

Salt Lake City, UT

2023 - 2019

  • Analyzed data of drug utilization and optimized medication cabinets
  • Identified gaps in care with medication reconciliations
  • Gave presentations to patient groups and educated individual patients on guideline-directed therapies across all units in the hospital

Pharma Industry, Pharmacist Intern Advanced Experience

Ionis Pharmaceuticals

Carlsbad, CA

2022 (6wks)

  • Analyzed new therapies for rare diseases and helped determined gaps in research

Research Publications

Types of Research Executed
Real-World Evidence
Economic Modeling
Literature Review



Therapeutic Area Exposure
Cardiovascular
Oncology
Immunology
Neurology
Rare Disease

Utilization of Guideline-Directed Medical Therapies in finerenone users

Zihe Zheng, Samuel T. Fatoba, Matthew Novin, Yunxun Wang, Arvind Katta, Jacob Earl, Jon W. Mares, German Guerrero, Marco Lavagnino, Youssef M.K. Farag, Connor W. Mckee, Wei Huang, Hongping Tian, Rakesh Singh, Yuxian Du, Drew Rockett, Karthik Sankaralingam

N/A

2025

  • Manuscript in Progress

Utilization of non-steroidal Mineralocorticoid Receptor Antagonist (MRA) finerenone with or without prior steroidal MRA

Zihe Zheng, Samuel T. Fatoba, Matthew Novin, Yunxun Wang, Arvind Katta, Jacob Earl, Jon W. Mares, German Guerrero, Marco Lavagnino, Youssef M.K. Farag, Connor W. Mckee, Wei Huang, Hongping Tian, Rakesh Singh, Yuxian Du, Drew Rockett, Karthik Sankaralingam

N/A

2025

  • Manuscript in Progress

Identifying and Characterizing Commercially Insured HFpEF Patients with High vs. Low Utilization

Jacob Earl, Ryan Hansen, Laura Hart

N/A

2025

  • Manuscript in Progress

Genetic Biomarkers in Multiple Sclerosis: An Umbrella Review of Meta-Analyses of Observational Studies

Adelaide Tempest, Sajesh K Veettil, Mari Kannan Maharajan, Jacob Earl, Surachat Ngorsuraches, Nathorn Chaiyakunapruk

N/A

2022

Cost-Effectiveness Analysis of Five Anti-Obesity Medications from a US Payer’s Perspective

Ainhoa Gomez-Lumbreras, Malinda S Tan, Lorenzo Villa Zapata, Sabrina Ilham, Jacob Earl, Daniel C Malone

N/A

2020

Posters & Conference Presentations

Real-World (RW) treatment patterns and clinical outcomes of patients treated with sequential regorafenib (R) and trifluridine/tipiracil (T) ± bevacizumab (BEV) for metastatic colorectal cancer (mCRC) in the United States (US) community oncology setting: The SEQRT2 study

Tanios Bekaii-Saab, David Cosgrove, Ila Sruti, Junxin Shi, Wei Dai, Gregory Patton, Sreevalsa Appakkuttan, Brian Hocum, Arvind Katta, Jacob Earl, Svetlana Babajanyan, Afsaneh Barzi

N/A

2025

  • Abstract and Poster Presentation at ASCO Genitourinary Symposium

Utilization of Guideline-Directed Medical Therapies in finerenone users

Zihe Zheng, Samuel T. Fatoba, Matthew Novin, Yunxun Wang, Arvind Katta, Jacob Earl, Jon W. Mares, German Guerrero, Marco Lavagnino, Youssef M.K. Farag, Connor W. Mckee, Wei Huang, Hongping Tian, Rakesh Singh, Yuxian Du, Drew Rockett, Karthik Sankaralingam

N/A

2024

  • Poster Presentation at American Society of Nephrology Kidney Week

Utilization of non-steroidal Mineralocorticoid Receptor Antagonist (MRA) finerenone with or without prior steroidal MRA

Zihe Zheng, Samuel T. Fatoba, Matthew Novin, Yunxun Wang, Arvind Katta, Jacob Earl, Jon W. Mares, German Guerrero, Marco Lavagnino, Youssef M.K. Farag, Connor W. Mckee, Wei Huang, Hongping Tian, Rakesh Singh, Yuxian Du, Drew Rockett, Karthik Sankaralingam

N/A

2024

  • Poster Presentation at American Society of Nephrology Kidney Week

Healthcare Resource Utilization Among Adults in North America with Heart Failure

Jacob Earl, Ryan Hansen, Laura Hart

N/A

2023

  • Poster Presentation at Corporate Advisory Board Meeting UW CHOICE Institute

The Effects of Bupropion in the Brains of Mice with METH-induced toxicity

Jacob Earl, Anne Gibson, Kristen Keefe

N/A

2023

  • Poster Presentation at the Society for Neuroscience

Learning from Learners: A Proactive Mindset to Improve

Nicholas Cox, Kyle Turner, Jacob Earl

N/A

2023

  • Oral presentation at both UPHA and USHP Annual Meetings

Leadership Experience

Diabetes Empowerment Program (DEP) Pharmacist Representative

Midvalley Community Clinic

Murray, Utah

2023 - 2022

  • Generated educational slide decks and presented content in Spanish

Project & Research Development Teaching Assistant

University of Utah College of Pharmacy

Salt Lake City, Utah

2023 - 2022

  • Mentored and educated students in presentation of research and methodology

Maliheh Community Clinic Director

Maliheh Community Clinic

Millcreek, Utah

2022 - 2021

  • Expanded clinic and provided free care to the underserved population

References Available Upon Request